Pleurocidin [V12,16A]

General Information


DRACP ID  DRACP04578

Peptide Name   Pleurocidin [V12,16A]

Sequence  GWGSFFKKAAHAGKHAGKAALTHYL

Sequence Length  25

UniProt ID  P81941 

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Active ACP



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antibacterial



Structure Information


PDB ID  6RSG 

Predicted Structure  Not available

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Amidation

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C125H184N36O29

Absent amino acids  CDEIMNPQRV

Common amino acids  A

Mass  308335

Pl  10.87

Basic residues  7

Acidic residues  0

Hydrophobic residues  11

Net charge  7

Boman Index  -954

Hydrophobicity  -26

Aliphatic Index  55.2

Half Life 
  Mammalian: 30 hour
  Yeast: >20 hour
  E.coli: >10 hour

Extinction Coefficient cystines  6990

Absorbance 280nm  291.25

Polar residues  7

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 33247193

Title  A pleurocidin analogue with greater conformational flexibility, enhanced antimicrobial potency and in vivo therapeutic efficacy

Doi Not available

Year  2020

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DBAASP ID  20614

DRACP is developed by Dr.Zheng's team.